Teen Marijuana E-cigarette Use Doubles in the US and Canada

May.07.2022
Teen Marijuana E-cigarette Use Doubles in the US and Canada
Teen vaping of cannabis e-cigarettes has doubled since 2013, reaching 13.6% in 2020, while smoking rates continue to decline.

According to a recent study published in JAMA Pediatrics, the prevalence of marijuana e-cigarette use among teenagers has doubled from 2013 to 2020. In 2018 alone, approximately one-third of 12th-grade students consumed marijuana.


A commentary has analyzed 17 studies conducted in the United States and Canada between 2015 and 2021, involving a total of 198,845 surveyed adolescents. Titled "Prevalence of adolescent marijuana and e-cigarette use: A systematic review and meta-analysis of US and Canadian studies," the analysis found that the lifetime prevalence of marijuana e-cigarette use rose from 6.1% in 2013 to 13.6% in 2020. Furthermore, between 2017 and 2020, the prevalence of marijuana e-cigarette use doubled, increasing from 7.2% to 13.2%. Additionally, from 2013 to 2020, the 30-day prevalence increased by 7 times, from 1.6% to 8.4%.


According to the author, one possible explanation for the observed increase in popularity of cannabis e-cigarette use within the time frame studied is the expansion of opportunities to acquire cannabis e-cigarette products, particularly among young people who commonly use e-cigarette products. This expansion is thought to be driven, in part, by the legalization of cannabis, which has reduced the perceived risk associated with its use over the last decade.


Smoking rates have decreased.


Meanwhile, a recent tobacco and nicotine survey in Canada showed that smoking rates for this particular age group decreased by 40% from 13.3% to 8% between 2019-2020. This figure is encouraging for Canada's Health Department's goal of a 5% smoking prevalence rate by 2035. Additionally, the 15-19 age group has already achieved this target, with current smoking rates not exceeding 5%.


In a letter to Patty Hajdu, the Minister of Health and an economics professor and medical researcher at Concordia University, Ian Irvine of the Howe Institute expressed disappointment about the media's selective coverage of vaping-related issues. Irvine stated that the media has largely overlooked important accomplishments in this field and instead has focused on the concept of vaping as a popular trend among this age group.


Irvine emphasized that although smoking rates have been decreasing due to government policies on tobacco, a true change occurred with the emergence of e-cigarette products. "By 2013, the smoking rate among the 15-19 age group had dropped to 11%, 18% among the 20-24 age group, and 16% among those 25 and older...then a disruptive technology appeared - e-cigarettes.


Source: Vaping Post.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Perak to stop issuing new vape licences, aiming for a phased “zero sales” outcome after October
Perak to stop issuing new vape licences, aiming for a phased “zero sales” outcome after October
Perak executive councillor Datuk Sivanesan said the state government aims to progressively reach a “zero” level of vape sales no later than after October, noting vape operators were clearly informed in October 2025.
Jan.05 by 2FIRSTS.ai
Kansas Lawmakers Hear SB 355 to License E-Cigarette Makers, Citing Illicit China Imports
Kansas Lawmakers Hear SB 355 to License E-Cigarette Makers, Citing Illicit China Imports
Kansas lawmakers held a Senate committee hearing on Senate Bill 355 on Jan. 27. The proposal would require e-cigarette manufacturers—potentially affecting distributors as well—to obtain a state license, expanding oversight beyond retailers.
Jan.28 by 2FIRSTS.ai
Before the Boom:  Why Manufacturing Is Becoming the Deciding Factor in U.S. Nicotine Pouches — An Interview with Rena World
Before the Boom: Why Manufacturing Is Becoming the Deciding Factor in U.S. Nicotine Pouches — An Interview with Rena World
As the U.S. nicotine pouch market moves toward regulatory clarity and rapid growth, attention is shifting from demand to execution. In an interview with 2Firsts, U.S.-based manufacturer Rena explains why manufacturing capacity, quality systems, and compliance readiness are becoming decisive factors before the market fully takes off.
Jan.19
Russia’s Rostov Region Eyes Full Vape Sales Ban, Signals Tighter Tobacco Retail Rules
Russia’s Rostov Region Eyes Full Vape Sales Ban, Signals Tighter Tobacco Retail Rules
Russia’s Rostov region is preparing to pursue a region-wide ban on vape sales and is also signaling support for broader regional powers to tighten tobacco retail rules. A regional lawmaker said the initiative aligns with a State Duma bill that would allow regions to impose vape sales bans—an initiative he said has presidential backing.
Jan.28 by 2FIRSTS.ai
Malaysia’s vape industry flags “policy U-turn” concerns after ban on refillable open-system e-cigarettes
Malaysia’s vape industry flags “policy U-turn” concerns after ban on refillable open-system e-cigarettes
Malaysia’s vape industry has raised concerns over the government’s decision to ban refillable open-system e-cigarettes, describing it as a policy reversal despite earlier regulatory approvals.
Jan.08 by 2FIRSTS.ai
Philippine FDA Requires Licenses for Vape Products with Medical Claims
Philippine FDA Requires Licenses for Vape Products with Medical Claims
The Philippine Food and Drug Administration has announced that establishments selling vaporized nicotine and non-nicotine products and novel tobacco products with medicinal or therapeutic claims must secure Licenses to Operate. Such products are also required to be registered as pharmaceutical products through the Center for Drug Regulation and Research. The FDA urged stakeholders to comply with the new requirements to ensure product safety, efficacy and quality.
Dec.22 by 2FIRSTS.ai